Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea
· Delayed Price · Currency is KRW 18,180
-830 (-4.37%)
Aug 14, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| Biochemical Diagnosis - Blood Sugar Meter | 58.73B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnosis - Blood Sugar Meter Growth | 23.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnosis - Glycated Hemoglobin Meter | 11.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnosis - Glycated Hemoglobin Meter Growth | 13.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnosis | 3.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunodiagnosis Growth | -98.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnosis | 3.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnosis Growth | 15.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnosis - Cholesterol/Liver Disease Meter | 2.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnosis - Cholesterol/Liver Disease Meter Growth | 2.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise | 1.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise Growth | -30.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product | 443.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Product Growth | 58.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnosis - Other | 39.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biochemical Diagnosis - Other Growth | -29.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 14.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -95.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnostics Kit - Merchandised | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Molecular Diagnostics Kit - Merchandised Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Others - Manufactured Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Others - Manufactured Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 14.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -95.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| Other | 7.91B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 46.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 24.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 19.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 16.01B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -10.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South America | 13.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South America Growth | 63.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 11.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 7.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 6.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | -97.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 7.91B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 46.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|